RD

Radharaman Dwivedi

Director Director DIN 10181682
DIN 10181682 First appointment May 2023 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2023
Shareholding value Locked Premium profile

About Radharaman Dwivedi

Data last updated:

Radharaman Dwivedi has 3 years in corporate governance. Formerly with 1 company, such as Suncross Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10181682
Primary Designation Director
First Appointment 29 May 2023
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director29 May 20232023Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Suncross Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Radharaman Dwivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Radharaman Dwivedi

Radharaman Dwivedi has 3 years in corporate governance. Formerly with 1 company, such as Suncross Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Radharaman Dwivedi is associated with 0 companies as a director.

Radharaman Dwivedi has expertise in General Business.

Radharaman Dwivedi has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available